Skip to main content

Table 1 Characteristics of patients and tumours in the two groups

From: Assessment and validation of the internal gross tumour volume of gastroesophageal junction cancer during simultaneous integrated boost radiotherapy

Characteristics

Group A [n = 10]

Group B [n = 9]

Age

 Median (range)

64 (54–64)

56 (36–69)

Gender (n, %)

 Male

9 (90)

6 (66.7)

 Female

1(10)

3 (33.3)

Siewert type (n, %)

 Siewert I

0 (0)

0 (0)

 Siewert II

2 (20)

4 (44.4)

 Siewert III

8 (80)

5 (55.6)

Tumour length

 Median (cm, range)

6 (4–8)

6 (4–13)

Clinical T stage (n, %)

 T3

1 (10)

1 (11.1)

 T4a

9 (90)

7 (77.8)

 T4b

0

1 (11.1)

Clinical N stage (n, %)

 N0

1 (10)

0

 N1

5 (50)

0

 N2

3 (30)

7 (77.8)

 N3

1 (10)

2 (22.2)

Clinical TNM stage (n, %)

 II

1 (10)

0

 IIIA

5 (50)

0

 IIIB

3 (30)

7 (77.8)

 IIIC

1 (10)

2 (22.2)